Harvest Fund Management Co. Ltd Cuts Stock Holdings in DaVita Inc. (NYSE:DVA)

Key Points

• Harvest Fund Management Co. Ltd cut its position in DaVita Inc. by 89.8% in the 1st quarter, reducing its holdings to just 533 shares valued at approximately $82,000.
• Insider James O. Hearty sold 2,351 shares of DaVita, resulting in an 8.28% decrease in his personal holdings, now totaling 26,038 shares.
• DaVita's stock is currently trading at $140.28, having a market cap of $10.59 billion, while analysts maintain a consensus rating of "Hold" with a price target of $167.40.

Harvest Fund Management Co. Ltd cut its position in DaVita Inc. (NYSE:DVA - Free Report) by 89.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 533 shares of the company's stock after selling 4,696 shares during the quarter. Harvest Fund Management Co. Ltd's holdings in DaVita were worth $82,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP boosted its stake in shares of DaVita by 9.1% in the 4th quarter. Wellington Management Group LLP now owns 2,711 shares of the company's stock valued at $405,000 after purchasing an additional 227 shares during the last quarter. Fifth Third Bancorp raised its holdings in DaVita by 5.0% during the first quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock worth $654,000 after buying an additional 204 shares during the last quarter. Concurrent Investment Advisors LLC bought a new stake in DaVita during the 1st quarter worth approximately $223,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of DaVita by 22.5% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company's stock valued at $666,000 after purchasing an additional 800 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in shares of DaVita by 7.9% in the first quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company's stock valued at $8,452,000 after purchasing an additional 4,048 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of DVA stock traded down $1.93 during trading hours on Friday, reaching $138.44. The stock had a trading volume of 686,266 shares, compared to its average volume of 672,836. The stock's fifty day simple moving average is $140.44 and its 200 day simple moving average is $147.82. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12 month low of $131.76 and a 12 month high of $179.60. The firm has a market capitalization of $10.45 billion, a PE ratio of 13.72, a PEG ratio of 0.96 and a beta of 1.09.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The company had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period last year, the business earned $2.26 earnings per share. DaVita's revenue was up 5.0% compared to the same quarter last year. On average, equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Insider Transactions at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares in the company, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DVA. Truist Financial lowered their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $167.40.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.